Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.
about
Indocyanine green enhanced near-infrared laser treatment of murine mammary carcinomaInhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancerEffect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice.The Kadota Fund International Forum 2004--clinical group consensus.Comparison of optical and power Doppler ultrasound imaging for non-invasive evaluation of arsenic trioxide as a vascular disrupting agent in tumors.Arterial embolization hyperthermia using As2O3 nanoparticles in VX2 carcinoma-induced liver tumors.Tumour thermotolerance, a physiological phenomenon involving vessel normalisationNanoparticle preconditioning for enhanced thermal therapies in cancerVascular disrupting agent arsenic trioxide enhances thermoradiotherapy of solid tumors.Targeting the tumor vasculature: a strategy to improve radiation therapy.Association between arsenic exposure from drinking water and plasma levels of cardiovascular markersAssociation between arsenic exposure from drinking water and plasma levels of soluble cell adhesion molecules.Tissue physiology and the response to heat.Arsenic Trioxide as a Vascular Disrupting Agent: Synergistic Effect with Irinotecan on Tumor Growth Delay in a CT26 Allograft Model.Development and modeling of arsenic-trioxide-loaded thermosensitive liposomes for anticancer drug deliveryAngiogenesis and vascular targeting: relevance for hyperthermia.Challenges in the development of magnetic particles for therapeutic applications.Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEAMild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factorsRealistic biological approaches for improving thermoradiotherapy.Arsenic trioxide increases the sensitivity of 786-0 renal carcinoma cells to radiotherapy.Assessing pH and oxygenation in cryotherapy-induced cytotoxicity and tissue response to freezing.Arsenic trioxide induces selective tumour vascular damage via oxidative stress and increases thermosensitivity of tumours.Cocaine and arsenic-induced Raynaud's phenomenon.Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells.Inhibition of angiogenesis by arsenic trioxide via TSP-1-TGF-β1-CTGF-VEGF functional module in rheumatoid arthritis.Therapeutic potential of using the vascular disrupting agent OXi4503 to enhance mild temperature thermoradiation.A phase I study to study arsenic trioxide with radiation and hyperthermia in advanced head and neck cancer.
P2860
Q24635149-86D88840-7EBC-45B6-801B-367066541BFBQ33258696-9E14B03E-7F88-4878-ACE3-9FF4713CCD08Q33312494-F0AC992B-AA45-4CB6-96B0-FBBB0D9E8F2EQ33320286-0EA4A75D-D66A-4C43-A303-873573D59559Q34430810-62228118-E218-4291-8A7B-67C7B8268398Q34712590-377DAB80-0041-4611-9034-2A7CB961B76FQ34916042-2BA4C6E1-3144-4971-B937-94F27F33C54BQ34987068-2223AD06-11AE-4577-95BC-6635FFCEB1C1Q35681405-4D9DA726-382C-44C2-BD1A-4D5A06E33950Q35728789-257A4199-C098-4CB1-BCCE-33D5CF9DFFFEQ36023464-C64DC4CB-24BD-4753-9AEE-8D672747AC1FQ36064959-AA8040E8-232D-4B20-9DED-2E74D6218E02Q36497614-A6E12C7C-032D-4160-8E99-F3EE827FCB21Q36613318-B84E44DC-816A-41FA-8DD3-E13868E86319Q36739924-311BB3AB-5271-4828-B756-6CDCBA5794F4Q37063496-97E3F623-26D3-479B-BAF7-C451C8AAD1E0Q37209899-F6E4C430-8A58-482D-A344-8465826E79FCQ37446120-E8EDD2E0-5F3B-4E39-91DB-A8A3070EF365Q37704374-686DCBEE-2EAE-4C97-8E8F-5D6F3EF4E628Q38648236-C7528820-219C-4C5C-9247-3687F492E816Q39431776-7CF195C9-1F70-4905-A9F6-628F2071D630Q40552361-D386434C-BED2-46CF-AC34-40A6D9A3E399Q40593312-7A9507EE-EE5E-44AE-B8E3-5F9D3D11ADE2Q44150211-9E6BB967-986E-4992-8732-B4913627ADAFQ45114054-437D89F3-8295-4D28-B1AE-296AA7E2B9FCQ47164886-B757A9DC-9EF3-4B0A-80BD-97717FE46CF7Q51029869-B0B84D64-8833-42A1-BBCD-0F276E897ECEQ53606948-58C33D54-A266-4D6C-AC63-66FC2B87FE5F
P2860
Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.
@ast
Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.
@en
Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.
@nl
type
label
Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.
@ast
Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.
@en
Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.
@nl
prefLabel
Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.
@ast
Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.
@en
Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.
@nl
P2093
P2860
P356
P1433
P1476
Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.
@en
P2093
M J Stewart
R J Griffin
P2860
P304
P356
10.1038/SJ.NEO.7900123
P577
2000-11-01T00:00:00Z